The Royal Marsden offers a range of myeloma treatment and care services for patients at its hospitals in Chelsea, London, and Sutton, Surrey.

Myeloma services at The Royal Marsden

  • Diagnosis, tests and investigations: primary assessment and diagnosis in partnership with other hospitals
  • Cancer genetics
  • Chemotherapy
  • Radiotherapy
  • Stem cell transplant, total body irradiation
  • Critical care
  • Rehabilitation, including a pre-transplant programme
  • Palliative and supportive care

Services are provided through a specialised inpatient unit for the delivery of more intensive chemotherapy and a newly refurbished outpatient area

Primary assessment and diagnosis

  • Full blood count
  • Biochemistry
  • Immunoglobulins testing
  • Paraprotein testing
  • Serum free light chain measurement
  • Bone marrow estimation
  • Skeletal surveys
  • MRI
  • PET CT
  • Bone marrow genetics
  • FISH (fluorescence in situ hybridisation)
  • Cytogenetics
  • Novel prognostic markers


  • Stem cell transplants (autologous and allogeneic donor transplants)
  • Chemotherapy using drugs such as Thalidomide, Velcade and Revlimid
  • Intensive strategies for aggressive disease
  • Access to novel drugs and clinical trials

Patient care and support

  • Clinical nurse specialist in myeloma
  • Specialist transplant nurses
  • Pain control
  • Orthopaedic and renal links